Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Exploring The Gut-Brain Axis: New Biotech Kallyope

This article was originally published in Scrip

Executive Summary

The end of 2015 saw the emergence of a new biotech company, Kallyope, with a focus on the gut-brain axis.

Advertisement

Related Content

Science Matters: Insights Into Gut-Brain Signaling Raise Hopes For Treating Neurological Disorders

Topics

Advertisement
UsernamePublicRestriction

Register